Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC 50 value of 0.5 nM.Form:Solid.
Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC 50 value of 0.5 nM.Form:Solid.
Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC 50 value of 0.5 nM.Form:Solid.
Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC 50 value of 0.5 nM.Form:Solid.
Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC 50 value of 0.5 nM.Form:Solid.
Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC 50 value of 0.5 nM.Form:Solid.
[8]-Shogaol, one of the pungent phenolic compounds in ginger, exhibits anti-platelet activity ( IC 50 =5 μM) and inhibits COX-2 ( IC 50 =17.5 μM). [8]-Shogaol induces apoptosis in human leukemia cells.
[8]-Shogaol, one of the pungent phenolic compounds in ginger, exhibits anti-platelet activity ( IC 50 =5 μM) and inhibits COX-2 ( IC 50 =17.5 μM). [8]-Shogaol induces apoptosis in human leukemia cells.
[8]-Shogaol, one of the pungent phenolic compounds in ginger, exhibits anti-platelet activity ( IC 50 =5 μM) and inhibits COX-2 ( IC 50 =17.5 μM). [8]-Shogaol induces apoptosis in human leukemia cells.Form:Liquid.
[8]-Shogaol, one of the pungent phenolic compounds in ginger, exhibits anti-platelet activity ( IC 50 =5 μM) and inhibits COX-2 ( IC 50 =17.5 μM). [8]-Shogaol induces apoptosis in human leukemia cells.Form:Liquid.
[8]-Shogaol, one of the pungent phenolic compounds in ginger, exhibits anti-platelet activity ( IC 50 =5 μM) and inhibits COX-2 ( IC 50 =17.5 μM). [8]-Shogaol induces apoptosis in human leukemia cells.Form:Liquid.
[8]-Shogaol, one of the pungent phenolic compounds in ginger, exhibits anti-platelet activity ( IC 50 =5 μM) and inhibits COX-2 ( IC 50 =17.5 μM). [8]-Shogaol induces apoptosis in human leukemia cells.Form:Liquid.
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC 50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with K d of 0.34 nM (37 °C, 2 h).
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC 50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with K d of 0.34 nM (37 °C, 2 h).
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC 50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with K d of 0.34 nM (37 °C, 2 h).
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC 50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with K d of 0.34 nM (37 °C, 2 h).
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC 50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with K d of 0.34 nM (37 °C, 2 h).
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC 50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with K d of 0.34 nM (37 °C, 2 h).